Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the ...

Teladoc Health announced Wednesday that it is launching two new AI-powered capabilities built into its Solo smart care ...

Trilliant Health’s report identifies six trends highlighting how misaligned incentives are contributing to rising costs, poor ...

Cybersecurity leaders discussed how AI-driven cybersecurity attacks pose a new level of risk for hospitals and health systems ...

Nobody has ever needed convincing on what to fix. What they've lacked is a way to act on it themselves, in something close to ...

Fraud, waste, and abuse (FWA) continue to challenge dental plans as overtreatment, miscoding and inappropriate billing ...

Launched last week, Facktor Ventures, an early-stage venture fund is taking a new approach to healthcare investing: they’re ...

The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in ...

Healthcare privacy teams are increasingly using artificial intelligence to automate the process of identifying, prioritizing, and investigating potential privacy violations. While the new technology ...

Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi ...

When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...